Minee’s research is centered on understanding of the mechanisms underlying protein aggregation, mitochondrial dysfunction, and neuroinflammation in neurodegenerative diseases, such as Alzheimer’s (AD) and Parkinson’s disease (PD). Her work aims to dissect the cellular processes involved in neurodegeneration and develop personalized therapeutic approaches for AD and PD. She extensively employs patient-derived pluripotent stem cell (hiPSC) systems, human cellular models for studying mitochondrial dysfunction and protein aggregation, as well as machine learning techniques.

Throughout her academic career, Minee has earned recognition for her contributions. She received the Imogen Rose Prize in 2010, awarded for her outstanding doctoral work at the University of Cambridge. The British Royal Society of Biology acknowledged her achievements in the field of neurodegeneration, granting her full membership in 2019. In 2021, she represented post-doctoral fellows of the British Neuroscience Association in the committee for the BNA 2021 conference. Furthermore, she served on the grant and fellowship committee of the Athena Swan program at the Crick Institute from 2019 to 2022, contributing to the empowerment of British female scientists. Since 2016, she has been an editorial board member for the Journal of Alzheimer’s, Parkinsonism, and Dementia. Since her appointment at KAIST in February 2023, she has achieved notable recognition, including the KAIST Q-day Special Prize for Creative Talent in the same year, as well as the KAIST Outstanding Lecture Award in 2024.